Alkermes plc. Comprehensive Income
Alkermes plc. (ALKS) reported Comprehensive Income of $486.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-28
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $486.00K, a 99.44% decline year-over-year.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$67.29M, a 392.86% decline year-over-year.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $48.30M, a 66.48% decline year-over-year.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $83.10M, a 13.79% decline year-over-year.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $241.53M, a 34.40% decline from fiscal 2024.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $368.21M, a 1.29% increase from fiscal 2023.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $363.54M.
- Alkermes plc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$165.43M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $486.00K 10-Q · filed 2026-07-28 | -$66.80M 10-Q · filed 2026-07-28 | -$18.50M derived: sum of 3 quarters · filed 2026-07-28 | $64.60M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$67.29M 10-Q · filed 2026-05-05 | -$18.99M derived: sum of 2 quarters · filed 2026-05-05 | $64.11M derived: sum of 3 quarters · filed 2026-05-05 | $151.27M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $48.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $131.40M derived: sum of 2 quarters · filed 2026-02-25 | $218.56M derived: sum of 3 quarters · filed 2026-07-28 | $241.53M 10-K · filed 2026-02-25 |
| 2025-09-30 | $83.10M 10-Q · filed 2025-10-28 | $170.25M derived: sum of 2 quarters · filed 2026-07-28 | $193.23M 10-Q · filed 2025-10-28 | $337.34M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $87.15M 10-Q · filed 2026-07-28 | $110.13M 10-Q · filed 2026-07-28 | $254.24M derived: sum of 3 quarters · filed 2026-07-28 | $350.64M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $22.98M 10-Q · filed 2026-05-05 | $167.09M derived: sum of 2 quarters · filed 2026-05-05 | $263.48M derived: sum of 3 quarters · filed 2026-05-05 | $354.85M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $144.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $240.51M derived: sum of 2 quarters · filed 2026-02-25 | $331.88M derived: sum of 3 quarters · filed 2026-02-25 | $368.21M 10-K · filed 2026-02-25 |
| 2024-09-30 | $96.40M 10-Q · filed 2025-10-28 | $187.76M derived: sum of 2 quarters · filed 2025-10-28 | $224.10M 10-Q · filed 2025-10-28 | $339.85M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $91.37M 10-Q · filed 2025-07-29 | $127.71M 10-Q · filed 2025-07-29 | $243.45M derived: sum of 3 quarters · filed 2026-02-25 | $292.57M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $36.34M 10-Q · filed 2025-05-01 | $152.08M derived: sum of 2 quarters · filed 2026-02-25 | $201.20M derived: sum of 3 quarters · filed 2026-02-25 | $438.96M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $115.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $164.86M derived: sum of 2 quarters · filed 2026-02-25 | $402.62M derived: sum of 3 quarters · filed 2026-02-25 | $363.54M 10-K · filed 2026-02-25 |
| 2023-09-30 | $49.12M 10-Q · filed 2024-10-24 | $286.88M derived: sum of 2 quarters · filed 2024-10-24 | $247.79M 10-Q · filed 2024-10-24 | $221.49M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $237.76M 10-Q · filed 2024-07-24 | $198.67M 10-Q · filed 2024-07-24 | $172.37M derived: sum of 3 quarters · filed 2025-02-12 | $106.04M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$39.09M 10-Q · filed 2024-05-01 | -$65.39M derived: sum of 2 quarters · filed 2025-02-12 | -$131.71M derived: sum of 3 quarters · filed 2025-02-12 | -$164.10M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$26.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$92.63M derived: sum of 2 quarters · filed 2025-02-12 | -$125.02M derived: sum of 3 quarters · filed 2025-02-12 | -$165.43M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$66.32M 10-Q · filed 2023-10-25 | -$98.71M derived: sum of 2 quarters · filed 2023-10-25 | -$139.13M 10-Q · filed 2023-10-25 | -$139.51M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$32.39M 10-Q · filed 2023-07-26 | -$72.80M 10-Q · filed 2023-07-26 | -$73.18M derived: sum of 3 quarters · filed 2024-02-21 | -$102.42M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$40.41M 10-Q · filed 2023-04-26 | -$40.79M derived: sum of 2 quarters · filed 2024-02-21 | -$70.03M derived: sum of 3 quarters · filed 2024-02-21 | -$67.94M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$29.62M derived: sum of 2 quarters · filed 2024-02-21 | -$27.52M derived: sum of 3 quarters · filed 2024-02-21 | -$50.54M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$29.24M 10-Q · filed 2022-11-02 | -$27.14M derived: sum of 2 quarters · filed 2022-11-02 | -$50.16M 10-Q · filed 2022-11-02 | -$93.39M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.09M 10-Q · filed 2022-07-27 | -$20.93M 10-Q · filed 2022-07-27 | -$64.16M derived: sum of 3 quarters · filed 2023-02-16 | -$64.95M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$23.02M 10-Q · filed 2022-04-27 | -$66.25M derived: sum of 2 quarters · filed 2023-02-16 | -$67.04M derived: sum of 3 quarters · filed 2023-02-16 | -$95.08M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$43.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$44.02M derived: sum of 2 quarters · filed 2023-02-16 | -$72.06M derived: sum of 3 quarters · filed 2023-02-16 | -$110.39M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$793.00K 10-Q · filed 2021-10-27 | -$28.83M derived: sum of 2 quarters · filed 2021-10-27 | -$67.16M 10-Q · filed 2021-10-27 | -$72.69M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$28.03M 10-Q · filed 2021-07-28 | -$66.37M 10-Q · filed 2021-07-28 | -$71.90M derived: sum of 3 quarters · filed 2022-02-16 | -$124.80M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$38.34M 10-Q · filed 2021-04-28 | -$43.87M derived: sum of 2 quarters · filed 2022-02-16 | -$96.77M derived: sum of 3 quarters · filed 2022-02-16 | -$137.87M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$58.43M derived: sum of 2 quarters · filed 2022-02-16 | -$99.53M derived: sum of 3 quarters · filed 2022-02-16 | -$195.16M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$52.90M 10-Q · filed 2020-10-29 | -$94.00M derived: sum of 2 quarters · filed 2020-10-29 | -$189.62M 10-Q · filed 2020-10-29 | -$198.95M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$41.09M 10-Q · filed 2020-07-29 | -$136.72M 10-Q · filed 2020-07-29 | -$146.05M derived: sum of 3 quarters · filed 2021-02-11 | -$180.18M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | -$95.63M 10-Q · filed 2020-04-29 | -$104.95M derived: sum of 2 quarters · filed 2021-02-11 | -$139.09M derived: sum of 3 quarters · filed 2021-02-11 | -$171.59M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$43.46M derived: sum of 2 quarters · filed 2021-02-11 | -$75.96M derived: sum of 3 quarters · filed 2021-02-11 | -$138.80M 10-K · filed 2021-02-11 |
| 2018-09-30 | -$34.13M 10-Q · filed 2019-10-23 | -$66.63M derived: sum of 2 quarters · filed 2019-10-23 | -$129.47M 10-Q · filed 2019-10-23 | -$139.80M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$32.50M 10-Q · filed 2019-07-25 | -$95.34M 10-Q · filed 2019-07-25 | -$105.67M derived: sum of 3 quarters · filed 2020-02-13 | -$141.86M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$62.84M 10-Q · filed 2019-04-25 | -$73.17M derived: sum of 2 quarters · filed 2020-02-13 | -$109.36M derived: sum of 3 quarters · filed 2020-02-13 | -$152.50M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$46.52M derived: sum of 2 quarters · filed 2020-02-13 | -$89.65M derived: sum of 3 quarters · filed 2020-02-13 | -$158.46M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$36.19M 10-Q · filed 2018-10-23 | -$79.33M derived: sum of 2 quarters · filed 2018-10-23 | -$148.13M 10-Q · filed 2018-10-23 | -$169.74M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$43.13M 10-Q · filed 2018-07-26 | -$111.94M 10-Q · filed 2018-07-26 | -$133.55M derived: sum of 3 quarters · filed 2019-02-15 | -$196.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | -$68.81M 10-Q · filed 2018-04-26 | -$90.42M derived: sum of 2 quarters · filed 2019-02-15 | -$153.36M derived: sum of 3 quarters · filed 2019-02-15 | -$200.24M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | -$21.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$84.56M derived: sum of 2 quarters · filed 2019-02-15 | -$131.43M derived: sum of 3 quarters · filed 2019-02-15 | -$207.92M 10-K · filed 2019-02-15 |
| 2016-09-30 | -$62.95M 10-Q · filed 2017-10-26 | -$109.83M derived: sum of 2 quarters · filed 2017-10-26 | -$186.31M 10-Q · filed 2017-10-26 | -$256.78M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$46.88M 10-Q · filed 2017-07-27 | -$123.37M 10-Q · filed 2017-07-27 | -$193.83M derived: sum of 3 quarters · filed 2018-02-16 | -$274.83M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$76.49M 10-Q · filed 2017-04-27 | -$146.96M derived: sum of 2 quarters · filed 2018-02-16 | -$227.96M derived: sum of 3 quarters · filed 2018-02-16 | -$274.14M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$70.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$151.47M derived: sum of 2 quarters · filed 2018-02-16 | -$197.66M derived: sum of 3 quarters · filed 2018-02-16 | -$227.82M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$81.00M 10-Q · filed 2016-11-02 | -$127.19M derived: sum of 2 quarters · filed 2016-11-02 | -$157.36M 10-Q · filed 2016-11-02 | -$127.11M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$46.19M 10-Q · filed 2016-07-28 | -$76.36M 10-Q · filed 2016-07-28 | -$46.11M derived: sum of 3 quarters · filed 2017-02-17 | -$86.22M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$30.17M 10-Q · filed 2016-04-28 | $77.00K derived: sum of 2 quarters · filed 2017-02-17 | -$40.03M derived: sum of 3 quarters · filed 2017-02-17 | -$47.05M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $30.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$9.87M derived: sum of 2 quarters · filed 2017-02-17 | -$16.89M derived: sum of 3 quarters · filed 2017-02-17 | -$43.77M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$40.11M 10-Q · filed 2015-10-29 | -$47.13M derived: sum of 2 quarters · filed 2015-10-29 | -$74.02M 10-Q · filed 2015-10-29 | -$50.95M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$7.02M 10-Q · filed 2015-07-30 | -$33.91M 10-Q · filed 2015-07-30 | -$10.84M derived: sum of 3 quarters · filed 2016-02-25 | -$10.09M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$26.89M 10-Q · filed 2015-04-30 | -$3.81M derived: sum of 2 quarters · filed 2016-02-25 | -$3.07M derived: sum of 3 quarters · filed 2016-02-25 | $3.85M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $23.07M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $23.81M derived: sum of 2 quarters · filed 2016-02-25 | $30.74M 10-K · filed 2016-02-25 | $33.88M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-30 | $744.00K 10-Q · filed 2014-10-29 | $7.67M 10-Q · filed 2013-10-31 | $10.81M 10-Q · filed 2014-10-29 | $27.20M derived: sum of 4 quarters · filed 2014-10-29 |
| 2013-06-30 | $6.93M 10-Q · filed 2014-07-31 | $10.07M 10-Q · filed 2014-07-31 | $26.46M derived: sum of 3 quarters · filed 2014-07-31 | $9.88M derived: sum of 4 quarters · filed 2014-07-31 |
| 2013-03-31 | $3.14M 10-Q · filed 2014-04-30 | $19.53M derived: sum of 2 quarters · filed 2014-04-30 | $2.96M derived: sum of 3 quarters · filed 2014-04-30 | $25.18M 10-K · filed 2015-02-24 |
| 2012-12-31 | $16.39M 10-Q · filed 2013-01-31 | -$184.00K derived: sum of 2 quarters · filed 2013-10-31 | $22.04M 10-Q · filed 2013-01-31 | -$41.11M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-09-30 | -$16.58M 10-Q · filed 2013-10-31 | $5.64M 10-Q · filed 2013-10-31 | -$57.51M derived: sum of 3 quarters · filed 2014-02-27 | -$72.34M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $22.22M 10-Q · filed 2013-07-25 | -$40.93M derived: sum of 2 quarters · filed 2014-02-27 | -$55.76M derived: sum of 3 quarters · filed 2014-02-27 | -$78.45M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$63.15M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | -$77.98M derived: sum of 2 quarters · filed 2014-02-27 | -$100.67M derived: sum of 3 quarters · filed 2014-02-27 | -$113.38M 10-KT · filed 2014-02-27 |
| 2011-12-31 | -$14.83M 10-Q · filed 2013-01-31 | -$37.52M derived: sum of 2 quarters · filed 2013-01-31 | -$50.23M 10-Q · filed 2013-01-31 | -$63.36M derived: sum of 4 quarters · filed 2013-05-23 |
| 2011-09-30 | -$22.69M 10-Q · filed 2012-11-01 | -$35.40M 10-Q · filed 2012-11-01 | -$48.53M derived: sum of 3 quarters · filed 2013-05-23 | -$60.43M derived: sum of 4 quarters · filed 2013-05-23 |
| 2011-06-30 | -$12.71M 10-Q · filed 2012-07-26 | -$25.84M derived: sum of 2 quarters · filed 2013-05-23 | -$37.74M derived: sum of 3 quarters · filed 2013-05-23 | -$44.95M derived: sum of 4 quarters · filed 2013-05-23 |
| 2011-03-31 | -$13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | -$25.03M derived: sum of 2 quarters · filed 2013-05-23 | -$32.25M derived: sum of 3 quarters · filed 2013-05-23 | -$45.16M 10-K · filed 2013-05-23 |
| 2010-12-31 | -$11.90M 10-Q · filed 2012-02-02 | -$19.11M derived: sum of 2 quarters · filed 2012-02-02 | -$32.03M 10-Q · filed 2012-02-02 | |
| 2010-09-30 | -$7.21M 10-Q · filed 2011-11-03 | -$20.13M 10-Q · filed 2011-11-03 | ||
| 2010-03-31 | -$36.53M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |